Skip to main content
← Back to sources

Benchling and Eli Lilly Partner to Give 1,300 Biotech Companies Access to AI Drug Discovery Models

Published 2026-01-08Enterprise AI DeliveryMedium

Summary

Benchling announced a strategic collaboration with Lilly TuneLab, an AI/ML platform created by Eli Lilly and Company, to provide Benchling's customer base of over 1,300 biotech companies with access to AI models trained on decades of Lilly's proprietary research data. The models, representing over $1 billion in research investment, cover drug disposition, safety, and preclinical datasets built from experimental data on hundreds of thousands of unique molecules. Through the partnership, scientis

Alignment: Reinforces current position
benchlingeli-lillybiotechdrug-discoveryfederated-learningai-modelsplatform-distributionhealthcare
Benchling and Eli Lilly Partner to Give 1,300 Biotech Companies Access to AI Drug Discovery Models — Intelligence — Agentic Developer Tools Radar · Signal